Casdin Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-165,000	Closed	-$4.64M	–	45
2022 Q3	$4.64M	Hold	165,000	–	–	0.3%	27
2022 Q2	$4.45M	Buy	+165,000	New	+$4.45M	0.38%	30